BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34471376)

  • 1. Genetic Polymorphisms of
    Zhang Y; Sun D
    Pharmgenomics Pers Med; 2021; 14():1047-1053. PubMed ID: 34471376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single Nucleotide Polymorphisms of FCRL3 in Iranian Patients with Behcet's Disease.
    Shahram F; Kazemi J; Mahmoudi M; Jadali Z
    Iran J Public Health; 2019 Jun; 48(6):1133-1139. PubMed ID: 31341856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of IL1R1 polymorphisms on the risk of head and neck cancer in Chinese Han population.
    Tian Y; Sun Y; Wu J; Xiong Z; Niu F; Li H; Liu Y; Liu J; Cai J
    Gene; 2020 Oct; 757():144927. PubMed ID: 32628975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Fc receptor-like 3 gene polymorphisms and susceptibility to autoimmune diseases: an updated meta-analysis.
    Yang Y; Su X; Zhang K; Zhou R
    Autoimmunity; 2013 Dec; 46(8):547-58. PubMed ID: 24117236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The high producer variant of the Fc-receptor like-3 (FCRL3) gene is involved in protection against multiple sclerosis.
    Matesanz F; Fernández O; Milne RL; Fedetz M; Leyva L; Guerrero M; Delgado C; Lucas M; Izquierdo G; Alcina A
    J Neuroimmunol; 2008 Mar; 195(1-2):146-50. PubMed ID: 18313765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The polymorphisms of
    Xiong W; Li Z; Zeng X; Cui J; Cheng Z; Yang X; Ding Y
    Front Oncol; 2023; 13():1100781. PubMed ID: 36998449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four FCRL3 Gene Polymorphisms (FCRL3_3, _5, _6, _8) Confer Susceptibility to Multiple Sclerosis: Results from a Case-Control Study.
    Yuan M; Wei L; Zhou R; Bai Q; Wei Y; Zhang W; Huang Y
    Mol Neurobiol; 2016 Apr; 53(3):2029-2035. PubMed ID: 25862376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fc receptor-like 1, 3, and 6 variants are associated with rheumatoid arthritis risk in the Chinese Han population.
    Yang Y; Li D; He C; Peng L; Xing S; Bai M; Rong H; Yuan D; He Y; He X; Wang L; Jin T
    Genes Environ; 2021 Oct; 43(1):42. PubMed ID: 34620245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.
    Gu LQ; Zhu W; Zhao SX; Zhao L; Zhang MJ; Cui B; Song HD; Ning G; Zhao YJ
    Clin Endocrinol (Oxf); 2010 Feb; 72(2):248-55. PubMed ID: 19438904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of CYP1A1 and CYP2D6 gene polymorphisms with head and neck cancer in Tunisian patients.
    Khlifi R; Chakroun A; Hamza-Chaffai A; Rebai A
    Mol Biol Rep; 2014; 41(4):2591-600. PubMed ID: 24449363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between RAD51 polymorphisms and susceptibility of head and neck cancer: a meta-analysis.
    Kong F; Wu J; Hu L; Du Y; Pan Y
    Int J Clin Exp Med; 2015; 8(4):6412-9. PubMed ID: 26131267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyroptosis and Inflammasome-Related Genes-
    Jing X; Yun Y; Ji X; Yang E; Li P
    Pharmgenomics Pers Med; 2023; 16():795-804. PubMed ID: 37650010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Response-Related Genes -
    Ma Y; Zhou Y; Zhang H; Su X
    Pharmgenomics Pers Med; 2020; 13():511-519. PubMed ID: 33116765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FCRL3 gene polymorphisms confer risk for sudden sensorineural hearing loss in a Chinese Han Population.
    Liu H; Gu Z; Kang HY; Ke X; Shen Y; Wang XQ; Hu GH; Zeng JH; Hong SL
    Gene; 2015 Oct; 570(1):89-94. PubMed ID: 26051414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer.
    Lee WT; Huang CC; Chen KC; Wong TY; Ou CY; Tsai ST; Yen CJ; Fang SY; Lo HI; Wu YH; Hsueh WT; Yang MW; Lin FC; Hsiao JR; Huang JS; Chang JY; Chang KY; Wu SY; Lin CL; Wang YH; Weng YL; Yang HC; Chang JS
    Oral Dis; 2015 Mar; 21(2):207-15. PubMed ID: 24724948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of in IL-1B/IL-1RN variants on the susceptibility to head and neck cancer in a chinese Han population.
    Yin Y; Li F; Tong L; Chen C; Yuan B
    Cancer Cell Int; 2021 Jan; 21(1):59. PubMed ID: 33472637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epistatic interaction between FCRL3 and MHC in Spanish patients with IBD.
    Martínez A; Núñez C; Martín MC; Mendoza JL; Taxonera C; Díaz-Rubio M; de la Concha EG; Urcelay E
    Tissue Antigens; 2007 Apr; 69(4):313-7. PubMed ID: 17389014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of inflammasome NLRP3, and IL1B and IL2 gene polymorphisms in periodontitis susceptibility.
    de Alencar JB; Zacarias JMV; Tsuneto PY; Souza VH; Silva COE; Visentainer JEL; Sell AM
    PLoS One; 2020; 15(1):e0227905. PubMed ID: 31978095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three SNPs of FCRL3 and one SNP of MTMR3 are associated with immunoglobulin A nephropathy risk.
    Zhang H; He Y; He X; Wang L; Jin T; Yuan D
    Immunobiology; 2020 Jan; 225(1):151869. PubMed ID: 31780315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians.
    Thabet MM; Wesoly J; Slagboom PE; Toes RE; Huizinga TW
    Ann Rheum Dis; 2007 Jun; 66(6):803-6. PubMed ID: 17179172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.